Forward Citations = 146

Loading Chart...

6 inventors (with patents filed for the assignee):

Robert P Geyer (4 out of 9 patents)

Vinod V Tuliani (4 out of 6 patents)

Robert T Lyons (1 out of 30 patents)

4. Albert J Owen, Iii (1 out of 8 patents)

5. Seang H Yiv (1 out of 7 patents)

6. Edward A Kaminski (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 5320848 - Chewable drug-delivery composition (1994-06-14),

2. 5310961 - Neomorphic ibuprofen (1994-05-10),

3. 5310960 - Low temperature process for preparing neomorphic ibuprofen (1994-05-10),

4. 5110606 - Non-aqueous microemulsions for drug delivery (1992-05-05),

5. 5073383 - Inhibiting aggregation in fluorocarbon emulsions (1991-12-17),

6. 4975528 - Process for separation and concentration of apolipoproteins using (1990-12-04),

7. 4975468 - Fluorinated microemulsion as oxygen carrier (1990-12-04),

Company Overview

Affinity Biotech, Inc. is a leading biotechnology company specializing in the development of innovative therapies for various diseases. With a strong focus on research and development, Affinity Biotech is dedicated to advancing medical science and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#41 in Malvern, PA

#1,438 in Pennsylvania

#39,929 in US

Malvern, PA, United States of America

Affinity Biotech, Inc.

Forward Citations = 146

6 inventors:

Robert P Geyer (4 out of 9 patents)

Vinod V Tuliani (4 out of 6 patents)

Robert T Lyons (1 out of 30 patents)

4. Albert J Owen, Iii (1 out of 8 patents)

5. Seang H Yiv (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Affinity Biotech, Inc.. Retrieved from https://idiyas.com/company/affinity-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]